The Alpha-fetoprotein (AFP) and albumin genes of the mouse provide a powerful model system for investigating the mechanisms by which organisms generate diversity in the patterns of gene expression. These genes are found tightly linked on mouse chromosome 5, and arose from 300 to 500 million years ago-as the result of a gene duplication. Their expression is co-activated in at least four separate cell lineages in the mouse; the visceral endoderm of the yolk sac, the fetal liver, gut and kidney. Yet within these tissues they exhibit very different rates of transcription, which, in the case of the AFP gene, change dramatically in liver after birth. This application wishes to address four issues. First, the DNA sequence elements responsible for the activation of these genes in the four lineages will be identified by gene transfer techniques into both tissue culture cells and mice. The sequences responsible for the postnatal suppression of the AFP gene will be identified by using the ability of AFP genes in transgenic mice to undergo selective repression. Second the tran-acting protein factors which recognize these elements will be identified and cloned using both biochemical and genetic selection methods. Third using teratocarcinoma cells as a model system, the role that cell-cell interaction plays in the decision of the primary endoderm to form either visceral or parietal endoderm will be investigated. In these studies we will focus on the role of the basement membrane in eliciting the secondary induction of the AFP gene during the maturation of the visceral endoderm, and will use anti-sense RNA strategies to interfere with the orderly development of the extra-cellular matrix. Fourth, the gene or genes responsible for that decision will be cloned using phenotypic selection schemes following gene transfer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37CA028050-08
Application #
3482106
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1979-08-01
Project End
1986-07-31
Budget Start
1986-05-01
Budget End
1986-07-31
Support Year
8
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Vogt, T F; Compton, R S; Scott, R W et al. (1988) Differential requirements for cellular enhancers in stem and differentiated cells. Nucleic Acids Res 16:487-500
Pachnis, V; Brannan, C I; Tilghman, S M (1988) The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J 7:673-81
Hammer, R E; Krumlauf, R; Camper, S A et al. (1987) Diversity of alpha-fetoprotein gene expression in mice is generated by a combination of separate enhancer elements. Science 235:53-8
Vogt, T F; Solter, D; Tilghman, S M (1987) Raf, a trans-acting locus, regulates the alpha-fetoprotein gene in a cell-autonomous manner. Science 236:301-3
Godbout, R; Ingram, R; Tilghman, S M (1986) Multiple regulatory elements in the intergenic region between the alpha-fetoprotein and albumin genes. Mol Cell Biol 6:477-87
Hammer, R E; Krumlauf, R; Camper, S et al. (1986) The regulation of alpha-foetoprotein minigene expression in the germline of mice. J Embryol Exp Morphol 97 Suppl:257-62
Krumlauf, R; Hammer, R E; Brinster, R et al. (1985) Regulated expression of alpha-fetoprotein genes in transgenic mice. Cold Spring Harb Symp Quant Biol 50:371-8
Tilghman, S M (1985) The structure and regulation of the alpha-fetoprotein and albumin genes. Oxf Surv Eukaryot Genes 2:160-206
Krumlauf, R; Hammer, R E; Tilghman, S M et al. (1985) Developmental regulation of alpha-fetoprotein genes in transgenic mice. Mol Cell Biol 5:1639-48